InsidersTradesSigma
Follow the Allergy Therapeutics Plc stock price and the full directors' dealings record of the company, a publicly traded company based in United Kingdom. Shares trade on the UK market, under the authority of RNS (LSE). Market capitalisation: €378.7m. The latest transaction was filed on 15 January 2025 (Purchase). Among the most active insiders: ZQ Capital Management Limited. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Allergy Therapeutics Plc es una empresa centrada en el desarrollo de tratamientos de inmunoterapia para alergias. Cotiza en la Bolsa de Valores de Londres.